Literature DB >> 21292896

Antileishmania immunological tests for asymptomatic subjects living in a visceral leishmaniasis-endemic area in Brazil.

Luciana Almeida Silva1, Héctor Dardo Romero, Gabriel Antônio Nogueira Nascentes, Roberto Teodoro Costa, Virmondes Rodrigues, Aluízio Prata.   

Abstract

The objective of this study was to evaluate the behavior of different tests used for the diagnosis of visceral leishmaniasis (VL) in asymptomatic subjects living in an endemic area. No gold standard is available for the diagnosis of asymptomatic infection with Leishmania. In continuation of a previous study, 1,017 subjects living in a VL-endemic area were clinically reevaluated. Of these, 576 had at least one positive serological test in a first assessment. About 3 years after the first evaluation, none of the subjects had progressed to clinical VL. Among this group, 246 subjects were selected, and five serological tests (enzyme-linked immunosorbent assay p [ELISAp], ELISArK39, ELISArK26, indirect immunofluorescence test [IIFT] using L. amazonensis promastigote antigen, and an immunochromatographic test using rK39 antigen [TRALd]) and the Montenegro skin test (MST) were repeated. There was a significant increase in the number of subjects who tested positive in the MST, IIFT, ELISAp, and ELISArK39 in the second evaluation. For all tests, there were subjects who tested positive in the first evaluation and negative in the second evaluation. A positive result in the serological tests and MST in subjects from the endemic area studied did not indicate a risk of progression to VL and may only be temporary.

Entities:  

Mesh:

Substances:

Year:  2011        PMID: 21292896      PMCID: PMC3029179          DOI: 10.4269/ajtmh.2011.10-0092

Source DB:  PubMed          Journal:  Am J Trop Med Hyg        ISSN: 0002-9637            Impact factor:   2.345


  29 in total

1.  RECENT RESEARCH ON KALA AZAR IN EAST AFRICA.

Authors:  P E MANSON-BAHR; B A SOUTHGATE
Journal:  J Trop Med Hyg       Date:  1964-04

2.  Randomized, double-blind, placebo-controlled study on the immunogenicity of the leishmanin skin test.

Authors:  P M De Luca; W Mayrink; M A Santiago; R Nogueira; F Conceição-Silva; G Mélo; S C F Mendonça
Journal:  Trans R Soc Trop Med Hyg       Date:  2003 Nov-Dec       Impact factor: 2.184

3.  Immunologic tests in patients after clinical cure of visceral leishmaniasis.

Authors:  Luciana De Almeida Silva; Héctor Dardo Romero; Aluízio Prata; Roberto Teodoro Costa; Evaldo Nascimento; Sílvio Fernandes Guimarães Carvalho; Virmondes Rodrigues
Journal:  Am J Trop Med Hyg       Date:  2006-10       Impact factor: 2.345

4.  Asymptomatic Leishmania chagasi infection in relatives and neighbors of patients with visceral leishmaniasis.

Authors:  A D'Oliveira Júnior; S R Costa; A B Barbosa; G Orge M de la; E M Carvalho
Journal:  Mem Inst Oswaldo Cruz       Date:  1997 Jan-Feb       Impact factor: 2.743

5.  Leishmanin test in Indian kala-azar.

Authors:  A B Neogy; A Nandy; B G Dastidar; A B Chowdhury
Journal:  Trans R Soc Trop Med Hyg       Date:  1986       Impact factor: 2.184

6.  Familial aggregation of Leishmania chagasi infection in northeastern Brazil.

Authors:  P H Cabello; A M Lima; E S Azevedo; H Krieger
Journal:  Am J Trop Med Hyg       Date:  1995-04       Impact factor: 2.345

7.  Loss of leishmanin skin test antigen sensitivity and potency in a longitudinal study of visceral leishmaniasis in Bangladesh.

Authors:  Caryn Bern; Josef Amann; Rashidul Haque; Rajib Chowdhury; Mustakim Ali; Katie M Kurkjian; Louise Vaz; Yukiko Wagatsuma; Robert F Breiman; W Evan Secor; James H Maguire
Journal:  Am J Trop Med Hyg       Date:  2006-10       Impact factor: 2.345

8.  New perspectives on a subclinical form of visceral leishmaniasis.

Authors:  R Badaro; T C Jones; E M Carvalho; D Sampaio; S G Reed; A Barral; R Teixeira; W D Johnson
Journal:  J Infect Dis       Date:  1986-12       Impact factor: 5.226

9.  Molecular characterization of a kinesin-related antigen of Leishmania chagasi that detects specific antibody in African and American visceral leishmaniasis.

Authors:  J M Burns; W G Shreffler; D R Benson; H W Ghalib; R Badaro; S G Reed
Journal:  Proc Natl Acad Sci U S A       Date:  1993-01-15       Impact factor: 11.205

10.  Visceral leishmaniasis in Somalia: prevalence of leishmanin-positive and seropositive inhabitants in an endemic area.

Authors:  S A Shiddo; H O Akuffo; A A Mohamed; G Huldt; L A Nilsson; O Ouchterlony; R Thorstensson
Journal:  Trans R Soc Trop Med Hyg       Date:  1995 Jan-Feb       Impact factor: 2.184

View more
  9 in total

1.  Asymptomatic Visceral Leishmania infantum Infection in US Soldiers Deployed to Iraq.

Authors:  Rupal M Mody; Ines Lakhal-Naouar; Jeffrey E Sherwood; Nancy L Koles; Dutchabong Shaw; Daniel P Bigley; Edgie-Mark A Co; Nathanial K Copeland; Linda L Jagodzinski; Rami M Mukbel; Rebecca A Smiley; Robert C Duncan; Shaden Kamhawi; Selma M B Jeronimo; Robert F DeFraites; Naomi E Aronson
Journal:  Clin Infect Dis       Date:  2019-05-30       Impact factor: 9.079

2.  Anti-leishmania infantum IgG antibody avidity in visceral leishmaniasis.

Authors:  Monique Gomes Salles Tiburcio; Laís Anversa; Kelly Aparecida Kanunfre; Antonio Walter Ferreira; Virmondes Rodrigues Júnior; Luciana de Almeida Silva
Journal:  Clin Vaccine Immunol       Date:  2013-09-04

3.  Infection with Leishmania (Leishmania) infantum of 0 to 18-Month-old children living in a visceral leishmaniasis-endemic area in Brazil.

Authors:  Danielle Borges Maciel; Thaís Almeida M Silva; Luciana Inácia Gomes; Edward de Oliveira; Monique Gomes Salles Tibúrcio; Rafael Faria de Oliveira; Daniel Avelar; José Ronaldo Barbosa; Eliana Furtado; Ana Rabello; Luciana de Almeida Silva
Journal:  Am J Trop Med Hyg       Date:  2014-06-16       Impact factor: 2.345

Review 4.  Unraveling the Role of Immune Checkpoints in Leishmaniasis.

Authors:  Rafael de Freitas E Silva; Esther von Stebut
Journal:  Front Immunol       Date:  2021-03-11       Impact factor: 7.561

Review 5.  Identification of asymptomatic Leishmania infections: a scoping review.

Authors:  Ana Victoria Ibarra-Meneses; Audrey Corbeil; Victoria Wagner; Chukwuemeka Onwuchekwa; Christopher Fernandez-Prada
Journal:  Parasit Vectors       Date:  2022-01-05       Impact factor: 3.876

6.  Validation of a mixture of rK26 and rK39 antigens from Iranian strain of Leishmania infantum to detect anti-Leishmania antibodies in human and reservoir hosts.

Authors:  Bibi Razieh Hosseini Farash; Mehdi Mohebali; Bahram Kazemi; Abdolmajid Fata; Homa Hajjaran; Behnaz Akhoundi; Reza Raoofian; Pietro Mastroeni; Elham Moghaddas; Azad Khaledi; Ghodratollah Salehi Sangani
Journal:  Sci Rep       Date:  2022-06-21       Impact factor: 4.996

Review 7.  A review of preventative methods against human leishmaniasis infection.

Authors:  Lisa Stockdale; Robert Newton
Journal:  PLoS Negl Trop Dis       Date:  2013-06-20

8.  Strong association between serological status and probability of progression to clinical visceral leishmaniasis in prospective cohort studies in India and Nepal.

Authors:  Epco Hasker; Paritosh Malaviya; Kamlesh Gidwani; Albert Picado; Bart Ostyn; Sangeeta Kansal; Rudra Pratap Singh; Om Prakash Singh; Ankita Chourasia; Abhishek Kumar Singh; Ravi Shankar; Mary E Wilson; Basudha Khanal; Suman Rijal; Marleen Boelaert; Shyam Sundar
Journal:  PLoS Negl Trop Dis       Date:  2014-01-23

9.  Leishmania infection in blood donors: A new challenge in leishmaniasis transmission?

Authors:  Adriana de Oliveira França; Mauricio Antonio Pompilio; Elenir Rose Jardim Cury Pontes; Márcia Pereira de Oliveira; Luiza Oliveira Ramos Pereira; Rosimar Baptista Lima; Hiro Goto; Maria Carmen Arroyo Sanchez; Mahyumi Fujimori; Manoel Sebastião da Costa Lima-Júnior; Maria de Fatima Cepa Matos; Maria Elizabeth Moraes Cavalheiros Dorval
Journal:  PLoS One       Date:  2018-06-14       Impact factor: 3.240

  9 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.